Saakshi Medtech & Panels Ltd
Saakshi Medtech & Panels Q4 FY24: Revenue ₹121.85 Cr
Q4 FY24 investor presentation: what the company reported on revenue, margins and projects.
Based on Saakshi Medtech & Panels Ltd's Q4 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Revenue for FY 23-24: Rs 121.85 Cr, slightly lower than FY 22-23 at Rs 122.05 Cr (Page 30, 23-24). EBITDA for FY 23-24: Rs 1,966.99 lakhs (down from Rs 2,055.95 lakhs in FY 22-23), indicating a slight YoY decrease.
From Saakshi Medtech & Panels Ltd's Q4 FY24 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Revenue for FY 23-24: Rs 121.85 Cr, slightly lower than FY 22-23 at Rs 122.05 Cr (Page 30, 23-24).
- Half-yearly revenue FY 23-24: H1 - Rs 53.27 Cr, H2 - Rs 68.92 Cr; FY 22-23 H1-H2 combined was Rs 122.6 Cr (Pages 25, 23).
- Revenue CAGR over last 5 years: 14.81% (Page 30).
- Segment sales FY 23-24 (Rs lakhs): Control Panels - 8883.57, Medical Devices - 400.67, Fabrication - 2714.72, Wire Harness - 184.68 (Page 14).
- Quarter-wise YoY changes not explicitly provided, but minor revenue dip from Rs 122.05 Cr to Rs 121.85 Cr year over year.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Saakshi Medtech & Panels Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Addition of new facility: 80,000 sq feet of industrial land with potential for 1,60,000 sq feet of constructed shop floor space (Page 11, 2024).
- Objective to consolidate business from 2 existing facilities into the new area in a phased manner (Page 11).
- New factory to focus on high-level assemblies & sheet metal canopies (Page 11).
- Construction timeline: Factory to be constructed in next 10 months and fully operational within 12 months (Page 11).
- Commercial production commenced at Factory Unit III in 2023 at Pimpri Chinchwad, MIDC Bhosari (Page 3).
- Addition of new machines for Unit 3 in FY 23-24, leading to increased depreciation (Page 29).
2 more points management made on capital expenditure plans
Top-ranked in Electrical Equipment
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Saakshi Medtech & Panels Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- New orders from L&T Defence already in hand worth Rs 150 Lakhs (Page 10).
- Post audit & NDA agreement with L&T Defence generated revenue of Rs 6.11 Lakhs till March 2024 (Page 10).
- First aviation client GE Aerospace completed 6 part numbers; additional business in phase 2 valued between INR 1 Cr to 3 Cr expected (Page 10).
- Export orders for locomotive parts to USA showing growth; exports business grew 27.7% YoY (Page 10).
2 more points management made on order book & pipeline
Continue your research
What Saakshi Medtech & Panels Ltd's management said in earlier quarters
Others in Electrical Equipment this season
- Advait Energy Transitions Limited (Q4 FY24)
For the quarter ending March 31, 2024, Advait Infratech reported standalone net sales of INR 59.71 crore. Key concall takeaways from Advait Energy Transitions…
- Oriana Power Ltd (Q4 FY24)
Revenue for FY24: ₹382.87 Crores, a 184.2% increase from ₹134.72 Crores in FY23 (Page 10, 7). Key concall takeaways from Oriana Power Ltd's Q4 FY24 earnings…
- KP Green Engineering Ltd (Q4 FY24)
Q3FY24 Revenue from Operations: ₹82.5 Crore, up 17% from ₹70.2 Crore in Q2FY24 (Page 12). Key concall takeaways from KP Green Engineering Ltd's Q4 FY24…
Frequently Asked Questions
What were Saakshi Medtech & Panels Ltd Q4 FY24 results?
Revenue for FY 23-24: Rs 121.85 Cr, slightly lower than FY 22-23 at Rs 122.05 Cr (Page 30, 23-24). EBITDA for FY 23-24: Rs 1,966.99 lakhs (down from Rs 2,055.95 lakhs in FY 22-23), indicating a slight YoY decrease.
What is Saakshi Medtech & Panels Ltd share price analysis?
Saakshi Medtech & Panels Ltd currently shows a neutral. The stock trades at a P/E of 53.6 with a market cap of ₹658 Cr. Investors should review the full earnings analysis for detailed insights.
Is Saakshi Medtech & Panels Ltd planning capital expenditure?
Addition of new facility: 80,000 sq feet of industrial land with potential for 1,60,000 sq feet of constructed shop floor space (Page 11, 2024).
Keep Saakshi Medtech & Panels Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.